HEALTHWAY Medical Corporation on Friday posted a loss of S$40.9 million for the three months as at end-December 2016, further widening from the S$904,000 loss in the same period a year ago.
As the fourth quarter figures were impacted by higher allowance for doubtful loan, trade and other receivables, which expanded to S$44.2 million in 2016, from S$3.8 million in 2015.
Revenue for the quarter came in marginally higher at S$23.4 million.
Loss per share in Q4 FY16 was 1.66 Singapore cents, compared with 0.04 S cent in the year-ago period.
388 total views, 1 views today